Literature DB >> 26642307

Functional imaging of interstitial brachytherapy in pancreatic carcinoma xenografts using spectral CT: how does iodine concentration correlate with standardized uptake value of (18)FDG-PET-CT?

Shudong Hu1,2, Xiaofeng Shi3, Yerong Chen1, Wei Huang2, Qi Song2, Xiaozhu Lin2, Yu Liu4, Kemin Chen2, Zhongmin Wang2.   

Abstract

OBJECTIVE: This study aimed to investigate the correlation between iodine concentration (IC) for the quantitative analysis of spectral CT and maximum standardized uptake value (SUVmax) of 18 fludeoxyglucose positron emission tomography-CT ((18)FDG PET-CT) as an indicator of therapeutic response to interstitial brachytherapy in transplanted human pancreatic carcinomas in BALB/c-nu mice.
METHODS: Xenograft models were created by subcutaneous injection of SW1990 human pancreatic cancer cell suspensions into immunodeficient BALB/c-nu mice. 30 mice bearing SW1990 human pancreatic cancer cell xenografts were randomly separated into two groups: experimental (n = 15; 1.0 mCi) and control (n = 15, 0 mCi). After 2 weeks of treatment, spectral CT and (18)FDG micro-PET-CT scan were performed. IC values and SUVmax in the lesions were measured. IC normalized to the muscle tissue is indicated as nIC. The relationships between the nIC and SUVmax of the transplantation tumours were analysed.
RESULTS: 2 weeks after treatment, the nIC in three-phase scans and SUVmax of the experimental group were significantly lower than those of the control group. The nIC values of the three-phase scans have certain positive correlation with the SUVmax values (r = 0.69, p < 0.05; r = 0.73 and p < 0.05; r = 0.80, p < 0.05 in the 10-, 25- and 60-s phase, respectively).
CONCLUSION: Spectral CT could serve as a valuable imaging modality, as our results suggest that nIC correlates with SUVmax of (18)FDG PET-CT for evaluating the therapeutic effect of (125)I interstitial brachytherapy in a pancreatic carcinoma xenograft. ADVANCES IN KNOWLEDGE: Spectral CT offers opportunities to assess the therapeutic response of pancreatic cancer. This study supports the conclusion that nIC values in spectral CT could also serve as a valuable functional imaging parameter for early monitoring and evaluation of the therapeutic response of (125)I interstitial brachytherapy mouse models because the nIC correlates with the SUVmax of (18)FDG PET-CT.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26642307      PMCID: PMC4985205          DOI: 10.1259/bjr.20150573

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  25 in total

1.  Role of FDG-PET/CT in diagnosis, staging, response to treatment, and prognosis of pancreatic cancer.

Authors:  Gaia Grassetto; Domenico Rubello
Journal:  Am J Clin Oncol       Date:  2011-04       Impact factor: 2.339

2.  Dual-energy (spectral) CT: applications in abdominal imaging.

Authors:  Alvin C Silva; Brian G Morse; Amy K Hara; Robert G Paden; Norio Hongo; William Pavlicek
Journal:  Radiographics       Date:  2011 Jul-Aug       Impact factor: 5.333

Review 3.  Recent developments of dual-energy CT in oncology.

Authors:  David Simons; Marc Kachelriess; Heinz-Peter Schlemmer
Journal:  Eur Radiol       Date:  2014-01-09       Impact factor: 5.315

4.  Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?

Authors:  G Schmid-Bindert; Thomas Henzler; T Q Chu; M Meyer; J W Nance; U J Schoepf; D J Dinter; P Apfaltrer; R Krissak; C Manegold; S O Schoenberg; C Fink
Journal:  Eur Radiol       Date:  2011-08-07       Impact factor: 5.315

5.  Spectral CT with metal artifacts reduction software for improvement of tumor visibility in the vicinity of gold fiducial markers.

Authors:  Olga R Brook; Sofia Gourtsoyianni; Alexander Brook; Anand Mahadevan; Carol Wilcox; Vassilios Raptopoulos
Journal:  Radiology       Date:  2012-03-13       Impact factor: 11.105

6.  Virtual monochromatic spectral imaging with fast kilovoltage switching: improved image quality as compared with that obtained with conventional 120-kVp CT.

Authors:  Kazuhiro Matsumoto; Masahiro Jinzaki; Yutaka Tanami; Akihisa Ueno; Minoru Yamada; Sachio Kuribayashi
Journal:  Radiology       Date:  2011-02-17       Impact factor: 11.105

7.  Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.

Authors:  Akinori Asagi; Koji Ohta; Junichirou Nasu; Minoru Tanada; Seijin Nadano; Rieko Nishimura; Norihiro Teramoto; Kazuhide Yamamoto; Takeshi Inoue; Haruo Iguchi
Journal:  Pancreas       Date:  2013-01       Impact factor: 3.327

8.  Comparison of response evaluation criteria in solid tumors with volumetric measurements for estimation of tumor burden in pancreatic adenocarcinoma and hepatocellular carcinoma.

Authors:  Jessemae L Welsh; Kellie Bodeker; Elizabeth Fallon; Sundershan K Bhatia; John M Buatti; Joseph J Cullen
Journal:  Am J Surg       Date:  2012-08-14       Impact factor: 2.565

9.  MicroPET-CT evaluation of interstitial brachytherapy in pancreatic carcinoma xenografts.

Authors:  Lu Jian; Wang Zhongmin; Chen Kemin; Zheng Yunfeng; Huang Gang
Journal:  Acta Radiol       Date:  2013-04-30       Impact factor: 1.990

10.  Dual-energy CT in assessing therapeutic response to radiofrequency ablation of renal cell carcinomas.

Authors:  Sung Yoon Park; Chan Kyo Kim; Byung Kwan Park
Journal:  Eur J Radiol       Date:  2013-12-04       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.